Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


2013 UCL Awards for Enterprise

Publication date: Jan 14, 2013 11:00 AM

Start: May 14, 2013 06:15 PM

Location: UCL Bloomsbury Theatre, Gordon Street, London

2013 UCL Awards for Enterprise

UCL Enterprise will be once again recognising the efforts and accomplishments of UCL’s innovative and entrepreneurial academics and students. UCL invites you to the 6th annual UCL Awards for Enterprise 2013.

On Tuesday 14th May 2013, UCL will honour a new generation of enterprise at the UCL Bloomsbury Theatre, London. The awards ceremony and reception will highlight UCL as a leading hub of innovation and commercial activity, while bringing together academics with businesses and investors.

Find out more at www.ucl.ac.uk/enterprise/awards2013